Institute of Radiation Physics, Lausanne University Hospital and Lausanne University, Lausanne, Switzerland.
RaySearch Laboratories, Stockholm, Sweden.
Radiother Oncol. 2024 May;194:110177. doi: 10.1016/j.radonc.2024.110177. Epub 2024 Feb 18.
Clinical translation of FLASH-radiotherapy (RT) to deep-seated tumours is still a technological challenge. One proposed solution consists of using ultra-high dose rate transmission proton (TP) beams of about 200-250 MeV to irradiate the tumour with the flat entrance of the proton depth-dose profile. This work evaluates the dosimetric performance of very high-energy electron (VHEE)-based RT (50-250 MeV) as a potential alternative to TP-based RT for the clinical transfer of the FLASH effect.
Basic physics characteristics of VHEE and TP beams were compared utilizing Monte Carlo simulations in water. A VHEE-enabled research treatment planning system was used to evaluate the plan quality achievable with VHEE beams of different energies, compared to 250 MeV TP beams for a glioblastoma, an oesophagus, and a prostate cancer case.
Like TP, VHEE above 100 MeV can treat targets with roughly flat (within ± 20 %) depth-dose distributions. The achievable dosimetric target conformity and adjacent organs-at-risk (OAR) sparing is consequently driven for both modalities by their lateral beam penumbrae. Electron beams of 400[500] MeV match the penumbra of 200[250] MeV TP beams and penumbra is increased for lower electron energies. For the investigated patient cases, VHEE plans with energies of 150 MeV and above achieved a dosimetric plan quality comparable to that of 250 MeV TP plans. For the glioblastoma and the oesophagus case, although having a decreased conformity, even 100 MeV VHEE plans provided a similar target coverage and OAR sparing compared to TP.
VHEE-based FLASH-RT using sufficiently high beam energies may provide a lighter-particle alternative to TP-based FLASH-RT with comparable dosimetric plan quality.
将 FLASH 放疗(RT)应用于深部肿瘤仍然是一项技术挑战。一种解决方案是使用约 200-250 MeV 的超高剂量率透射质子(TP)束,利用质子深度剂量分布的平坦入口照射肿瘤。本研究评估了超高能电子(VHEE)为基础的 RT(50-250 MeV)作为替代 TP 为基础的 RT 用于 FLASH 效应临床转化的潜在可能性的剂量学性能。
利用蒙特卡罗模拟在水中比较了 VHEE 和 TP 束的基本物理特性。使用 VHEE 功能的研究治疗计划系统评估了不同能量的 VHEE 束所能实现的计划质量,与 250 MeV 的 TP 束相比,评估了用于脑胶质瘤、食管癌和前列腺癌病例的计划质量。
与 TP 一样,超过 100 MeV 的 VHEE 可以治疗深度剂量分布大致平坦(在±20%以内)的靶区。因此,两种模式的靶区适形度和相邻危及器官(OAR)保护的可实现程度都取决于其侧向束半影。400[500] MeV 的电子束与 200[250] MeV 的 TP 束的半影相匹配,而较低电子能量的半影则增大。对于所研究的病例,能量为 150 MeV 及以上的 VHEE 计划实现了与 250 MeV 的 TP 计划相当的剂量学计划质量。对于脑胶质瘤和食管癌病例,尽管适形度降低,甚至 100 MeV 的 VHEE 计划也能提供与 TP 相似的靶区覆盖和 OAR 保护。
使用足够高的束能,基于 VHEE 的 FLASH-RT 可能为基于 TP 的 FLASH-RT 提供一种轻粒子替代方案,具有相当的剂量学计划质量。